121 related articles for article (PubMed ID: 2002090)
1. The relationship of interleukin-2 and soluble interleukin-2 receptors to intrathecal immunoglobulin synthesis in patients with multiple sclerosis.
Sharief MK; Hentges R; Thompson EJ
J Neuroimmunol; 1991 Apr; 32(1):43-51. PubMed ID: 2002090
[TBL] [Abstract][Full Text] [Related]
2. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
Sivieri S; Ferrarini AM; Gallo P
Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
[TBL] [Abstract][Full Text] [Related]
3. In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis.
Sharief MK; Hentges R; Ciardi M; Thompson EJ
J Neurol; 1993 Jan; 240(1):46-50. PubMed ID: 8423463
[TBL] [Abstract][Full Text] [Related]
4. Serum and CSF levels of IL-2, sIL-2R, TNF-alpha, and IL-1 beta in chronic progressive multiple sclerosis: expected lack of clinical utility.
Peter JB; Boctor FN; Tourtellotte WW
Neurology; 1991 Jan; 41(1):121-3. PubMed ID: 1985276
[TBL] [Abstract][Full Text] [Related]
5. Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.
Gallo P; Piccinno MG; Pagni S; Argentiero V; Giometto B; Bozza F; Tavolato B
J Neurol Sci; 1989 Aug; 92(1):9-15. PubMed ID: 2504888
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal synthesis of interleukin-2 and soluble IL-2 receptor in asymptomatic HIV-1 seropositive individuals. Correlation with local production of specific IgM and IgG antibodies.
Ciardi M; Sharief MK; Noori MA; Thompson EJ; Salotti A; Rossi F; Vullo V; Catania S; Sorice F; Cirelli A
J Neurol Sci; 1993 Mar; 115(1):117-22. PubMed ID: 8468587
[TBL] [Abstract][Full Text] [Related]
7. Correlation of interleukin-2 and soluble interleukin-2 receptor with clinical activity of multiple sclerosis.
Sharief MK; Thompson EJ
J Neurol Neurosurg Psychiatry; 1993 Feb; 56(2):169-74. PubMed ID: 8437006
[TBL] [Abstract][Full Text] [Related]
8. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
Adachi K; Kumamoto T; Araki S
Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
[TBL] [Abstract][Full Text] [Related]
9. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis.
Freedman MS; Muth KL; Trotter JL; Yoshizawa CN; Antel JP
Neurology; 1992 Aug; 42(8):1596-601. PubMed ID: 1641157
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
Fesenmeier JT; Whitaker JN; Herman PK; Walker DP
J Neuroimmunol; 1991 Oct; 34(1):77-80. PubMed ID: 1716642
[TBL] [Abstract][Full Text] [Related]
11. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.
Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH
Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845
[TBL] [Abstract][Full Text] [Related]
12. Intrathecal synthesis of IgG, IgA, IgM and IgD in untreated multiple sclerosis and controls.
Lolli F; Halawa I; Link H
Acta Neurol Scand; 1989 Sep; 80(3):238-47. PubMed ID: 2801020
[TBL] [Abstract][Full Text] [Related]
13. Importance of intrathecal synthesis of IgD in multiple sclerosis. A combined clinical, immunologic, and magnetic resonance imaging study.
Sharief MK; Hentges R
Arch Neurol; 1991 Oct; 48(10):1076-9. PubMed ID: 1929901
[TBL] [Abstract][Full Text] [Related]
14. High cerebrospinal fluid and serum levels of tumor necrosis factor-alpha in asymptomatic HIV-1 seropositive individuals. Correlation with interleukin-2 and soluble IL-2 receptor.
Ciardi M; Sharief MK; Thompson EJ; Salotti A; Vullo V; Sorice F; Cirelli A
J Neurol Sci; 1994 Sep; 125(2):175-9. PubMed ID: 7807163
[TBL] [Abstract][Full Text] [Related]
15. Soluble interleukin-2 receptor levels in cerebrospinal fluid of patients with acute lymphocytic leukemia or with non-Hodgkin's lymphoma.
Chang CS; Liu HW; Lin SF; Chen TP
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 May; 22(2):132-7. PubMed ID: 2605973
[TBL] [Abstract][Full Text] [Related]
16. A longitudinal study on IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis CSF and serum.
Gallo P; Piccinno MG; Tavolato B; Sidén A
J Neurol Sci; 1991 Feb; 101(2):227-32. PubMed ID: 1827837
[TBL] [Abstract][Full Text] [Related]
17. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-2, soluble interleukin-2-receptor, neopterin, L-tryptophan and beta 2-microglobulin levels in CSF and serum of patients with relapsing-remitting or chronic-progressive multiple sclerosis.
Ott M; Demisch L; Engelhardt W; Fischer PA
J Neurol; 1993 Dec; 241(2):108-14. PubMed ID: 8138825
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal immune response in patients with the post-polio syndrome.
Sharief MK; Hentges R; Ciardi M
N Engl J Med; 1991 Sep; 325(11):749-55. PubMed ID: 1651456
[TBL] [Abstract][Full Text] [Related]
20. MBP, anti-MBP and anti-PLP antibodies, and intrathecal complement activation in multiple sclerosis.
Sellebjerg F; Christiansen M; Garred P
Mult Scler; 1998 Jun; 4(3):127-31. PubMed ID: 9762660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]